Marketresearchnews

Friday, 1 February 2019

Prostate Laser Surgery Market - Granular Market Report and Review, 2018

The prevalence of prostate disorders has become widespread, and Market Research Future (MRFR) perceives the growth of the global prostate laser surgery market to be healthy at a CAGR of 7.2% over the forecast period of 2017-2023. Spiraling incidences of urology disorders such as benign prostatic hyperplasia (BPH) or enlargement of the prostate induces high demand for prostate laser surgery. Such disorders are more common among the geriatric population. Rising geriatric population across the globe is a prime factor in shaping the growth of the global prostate laser surgery market.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5108

A growing preference for minimally invasive surgical procedures is a significant factor in driving the growth of the global prostate laser surgery market. Laser surgery is associated with benefits such as speedy relief, minimal blood loss, and reduced post-operative complications.

Other driving factors include surging awareness about urological disorders, favorable reimbursement scenario, and continuous R&D efforts to improve laser surgical procedures. Besides, a growing number of FDA approvals for new laser devices stimulate the market growth. On the flip side, the market growth might be restricted by high costs of laser surgical procedures which hinders growth in cost-sensitive markets. Also, lack of awareness, affordability, and preference for other treatment options also limits the market growth considerably.

Segmentation

The global prostate laser surgery market has been segmented based on type, indication, and end user.

By type, the global prostate laser surgery market has been segmented into holmium laser ablation of the prostate, photoselective vaporization of the prostate, and holmium laser enucleation.

By indication, the global prostate laser surgery market has been segmented difficulty starting urination, slow urination, into benign prostatic hyperplasia, urinary tract infections, and others.

By end user, the global prostate laser surgery market has been segmented into hospitals & clinics, medical device companies, and others.

Regional Analysis

The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are the key markets for prostate laser surgery. The Americas led the global market due to heightened demand for advanced treatment options and high healthcare expenditure. Also, the concentration of major players in North America acts as a plus for the market growth.

Europe follows the Americas closely and is the second largest market for prostate laser surgery led by Germany and France. Extensive demand for advanced laser surgical devices coupled with rigorous R&D activities in the region supports the market growth. Moreover, the key players in the region are aiming towards product differentiation by the adoption of new technologies.

APAC market is likely to progress at a relatively faster rate over the forecast period. Increasing geriatric population, widespread prevalence of urology disorders and rapid adoption of advanced technologies spur the growth of the APAC market.

The MEA market is anticipated to exhibit steady growth over the forecast period due to improving the healthcare sector and growing awareness about urology disorders in the region.

Competitive Landscape

Medifocus Inc, and CoreTherm Medical Inc. (U.S.), Lumenis, Richard Wolf (U.S.), Olympus (Japan), Limmer Laser GmbH (Germany), Boston Scientific Corporation (U.S.), JenaSurgical GmbH (Germany), Urologix, LLC. (U.S.), Unique Medical Devices (India), and KARL STORZ SE & Co. KG (Germany) are the key players operating in the global prostate laser surgery market.

Industry Updates

In October 2018, Surgi Med Clinic Company Limited, introduced a new laser urology technology which can be used to treat stones in the kidney, bladder and also to treat the prostate.
In June 2018, a Swedish company Clinical Laserthermia Systems (CLS)and a Canadian company Exact Imaging entered into a partnership to market image-guided laser surgery to treat prostate cancer and benign prostatic hyperplasia.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/check-discount/5108

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Biological Computers Market 2018 Market Challenge, Driver, Trends & Forecast to 2023

Market Synopsis of the Global Biological computers Market

Biological computers, also known as DNA computers, are microcomputers designed for their use in the field of medicine. This implantable device can be used for various functions such as monitoring the activities of the body or inducing therapeutic effects. Hardware, software, input, and output are the four major components of a biological computer. These components are made of DNA, RNA and proteins. Biological computers are able to perform mathematical calculations that enable the researcher to construct a system of biosensors. This system of biosensors can detect or target specific types of cells such as cancer cells in the patient’s body.

Rising prevalence of cancer, and increasing demand for DNA or gene chips are some of the major factors driving the growth of this market across the globe. Furthermore, increasing healthcare expenditure and overall growth of the healthcare industry also influence the market growth. Splendid research in the field of oncology also boosts the market.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5067

As per the report of the Centers for Disease Control and Prevention (CDC), in 2014, over 14.1 million of new cancer cases were registered worldwide.

The global biological computers market is expected to grow at a CAGR of 7.1% during the forecast period 2017-2023.

Segments

The global biological computers market is segmented on the basis of component, application, and end user.

On the basis of the component, market is segmented into hardware, software, input, and output.

On the basis of the application, the market is segmented into oncology, molecular genetics, nanobiotechnology, and others.

On the basis of the end user, the market is segmented into pharmaceutical & biotechnology companies, research centers, healthcare it companies, hospital & clinics, and others.

Regional Analysis of the Global Biological Computers Market

The Americas hold the first position in the biological computers market owing to the rising prevalence of cancer in the U.S., and increasing demand for new cancer diagnostic and treatment services. In the Americas, North America is the largest market owing to the presence of key players in the healthcare IT industry.

Europe is the second largest market for biological computers. In Europe, there is an increasing demand for healthcare IT solutions and extensive research and development activities is taking place by clinical research and academic institutes for cancer treatment. According to Cancer Research UK, in 2014, 356,860 new cases of cancer were reported, including 579 cases of bone cancer.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the high prevalence of chronic disease such as cancer, obesity, diabetes and other. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand for technologically advanced medical devices and accessories such as gene chips for research activities. Availability of highly qualified medical professionals dedicated to research in biological systems is also a contributing factor. The various other factors affecting the growth of the market in Asia Pacific are rising geriatric population, demand for advanced therapies, government initiatives, and increasing public awareness about various diseases and the available treatments.

Additionally, healthcare spending in Asia Pacific expanded in 2016 due to an extension of state healthcare programs, and the increasing affluence of the population. Organization for Economic Co-operation and Development (ECOD) stated that growth in India will remain high at 7.3% in 2017.

The Middle East & Africa also show a steady rise in the market owing to low technological penetration and increasing awareness about cancer treatment. In the Middle East & Africa, Middle East captures the largest market share for biological medicines owing to the availability of better healthcare infrastructure and wide scope for research.

Key Players in the Global Biological computers Market

Some of the key players in this market are Microsoft (U.S.), IBM (U.S.), Thermofisher Scientific (U.S.), Illumina, Inc. (U.S.), IndieBio (U.S.), Emulate Inc. (U.S.), and others. Key players manufactruing DNA or gene chips are Sequenom Inc., Merck KGaA (U.S.), Macrogen Corp (Republic of Korea), Bioneer Corporation (Republic of Korea), Biometrix Technology Inc (U.S.), Wafergen Biosystems Inc. (U.S.), and Eurofins Genomics India Pvt Ltd. (India).

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/biological-computers-market-5067

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Smart Textile Market Value Share, Supply Demand, share and Value Chain 2018

Market Scenario:

Smart fabrics and textiles are new fields of research, which have wide applications in healthcare. Sensors that are integrated into textiles and have contact with the body are able to capture physiological signals. Recently, medical engineering has brought a revolution in the field of medicine promoting new methods for the treatment and diagnosis of diseases. The demand for medical sensors and monitoring devices, evolving methods of diagnosis, increasing burden of diseases, and extensive use of wearable medical devices are driving the growth of this market. The higher cost of smart textiles acts as a restraint for this market. The global market for medical smart textiles is expected to register a CAGR of approximately 9.5% during the forecast period 2018–2027.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1123

Segmentation

The Global Medical Smart Textile Market is segmented on the basis of technology, application, and end user.

By technology, the Global Medical Smart Textile Market is segmented into smart fabric technology, textile sensors, and wearable and joining technology.

By application, the Global Medical Smart Textile Market is segmented into surgery, hygiene, drug release systems, bio-monitoring, therapy, and wellness.

On the basis of end use, the Global Medical Smart Textile Market is segmented into hospitals, clinics, and others.

Key players

Google Inc. (US),
Intelligent Clothing Ltd. (UK),
International Fashion Machines (US),
Textronics, Inc. (US),
Interactivewear (Germany),
Sensoria Inc. (US),
Schoeller Textiles AG (Switzerland),
Vista Medical Ltd. (Canada),
Gentherm (US).

Regional Market Summary

The medical smart textile market is dominated by North America owing to the extensive use of medical devices and applications in medical engineering for monitoring vital health indicators. It consists of two regions, namely, North America and South America. Most of the market players are engaged in continuous technological advancements in medical devices for ease of diagnosis, monitoring, and treatment.

It is estimated that Europe stood second in the global medical smart textile market. Rising government initiatives to promote the healthcare sector and increased adoption of research and development activities in the healthcare domain drive the market in this region. Moreover, the entry of market leaders into strategic partnerships and collaborations with the chemical industry contributes to the growth of the market in Europe.

Asia-Pacific is likely to witness growth in the medical smart textile market during the forecast period owing to the increasing number of healthcare organizations, increasing prevalence of diseases, extensive demand for advanced medical devices, and increasing applications of technology in the early diagnosis of diseases. Moreover, the increasing prevalence of geriatric population in the region influences the market growth. China, India, and Japan are the key market players in this region and Asia-Pacific is expected to be the fastest growing market for medical smart textiles.

The Middle East and Africa holds the least share in the global medical smart textile market due to the presence of stringent government policies and poor economies.

Browse Complete 115 Pages Premium Research Report Enabled with 69 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/medical-smart-textile-market-1123

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Latest Study Offers Detailed Insights on Hemorrhoids Treatment Market 2018

Market Scenario:

The Global Hemorrhoids Treatment Market is expected to register a CAGR of ~5.5 % during the forecast period of 2018 to 2023.One of the most uncomfortable disorders a patient can have is hemorrhoids and most of the population under the age of fifty don’t know what hemorrhoids are. The general population avoids the disorder until they suffer from the disorder and start to feel the symptoms such as pain and itching associated with the condition. According to the American Society of Colon & Rectal Surgeons, hemorrhoids are one of the most common disorders and more than half the population will develop hemorrhoids after the age of 30. The prevalence of hemorrhoids (also called piles) in the United States is reported to be 4.4% with most suffering occurring between the ages of 45 and 65, equally in men and women. But only one third of these individuals seek medical treatment such as surgery, medication etc., with most opting for over-the-counter relief purchased from the pharmacies.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6999

There are two types of haemorrhoids (piles), internal and external, which differ to their location. While there is no exact cause of hemorrhoids, there variety of reasons that can subsidize to the disorder: aging, chronic constipation or diarrhea, pregnancy, heredity, straining during bowel movements, faulty bowel function. Some patients may not even experience symptoms but those that do may notice bleeding during bowel movements, protrusion during bowel movements and itching, pain, and sensitive lumps in the anal area. A variety of options exist for home treatment such as sitz baths, wipes, suppositories, creams, fiber supplements, and hemorrhoid pillows. Over half of patients purchasing hemorrhoid treatment use a cream. Preparation H and Tucks are the leading providers of creams, wipes/pads, and suppositories and can be purchased at most grocery and drug stores.

Segmentation:

The Global Hemorrhoids Treatment Market is segmented based on treatment type, route of administration, distribution channel, and region.On the basis of treatment type, the market is segmented into drugs (further sub segmented into laxatives, NSAIDs, and herbals) non-surgical procedures (further sub segmented into band litigation, sclerotherapy, cryotherapy) surgical procedures. Further, on the basis of route of administration the market is segmented into oral, topical agents. Distribution channel is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others.

Regional Market Summary:

In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa. More than half the population in the U.S. will be affected by hemorrhoids in their lives. Hemorrhoids are swollen, inflamed veins in the anal canal and can cause strong irritation in the form of pain and itching. Currently, patients suffering from hemorrhoids who seek relief from their discomfort can choose from an assortment of products with varying positives and negatives. Direct products such as creams, wipes, suppositories and pads are effective at providing temporary relief, but cannot be used for permanent treatment. Hemorrhoid cushions can be used as much as needed but are conspicuous and can be uncomfortable with prolonged use.Moreover, According to Home Care Magazine, in 2014, 24 million baby boomers had reached age 50. Those over age 65 will continue to represent a larger share of the overall population. By 2020, more than 54 million people in the United States will be over age 65. Furthermore, by 2030, members of the 66 to 84 age brackets will constitute an estimated 20 percent of the U.S. population.

Europe accounted for the second largest market behind Americas. Europe consist of two regions namely Western Europe and Eastern Europe. Western Europe holds the major share of the market, which is majorly contributed by Germany, the U.K., and France. The major factors accountable for the growth of the hemorrhoids treatment market comprise of sedentary lifestyle, lack of physical exercise, alcoholism, obesity, poor fiber intake in diet etc. in most of the regions in Europe. Lack of awareness and preparedness for medical treatment due to a feeling of embarrassment hinders the growth of the market.Asia Pacific is the fastest growing region in hemorrhoids market. Increasing need for better diagnostic devices, better and safe therapeutic approach, rapidly improving technology, and the presence of huge patient pool drive the growth of this market in Asia Pacific region.
Key players:

Some of the key players in the Global Hemorrhoids Treatment Market are Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline, Olympus Corporation, Pfizer Inc., Takeda Pharmaceutical Company, Taro pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Astra Zeneca, Glenmark Pharmaceuticals and others

Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/hemorrhoids-treatment-market-6999

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cardiac Valve Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2023

Market scenario

Cardiac valve or heart valve allows blood to flow in only one direction through the heart. Human heart consists of four valves. These valves open and closes compulsory on differential blood pressure on each side.

Increasing number of people with cardiovascular diseases and increasing number of cardiac surgery have stimulated the growth of the market. Additionally, increasing incident of diabetes and obesity, adoption of deskbound lifestyle rising geriatric population, and excessive use of tobacco and alcohol projected to propel the growth of the market.

On the other hand, high cost of treatment methods may hamper the growth of the global cardiac valve market over the forecast period.

The global cardiac valve market is expected to grow at a CAGR of 11.5% during the forecasted period.

Key players

Medtronic,
Edwards Lifesciences Corporation (U.S.),
Boston Scientific Corporation (U.S.),
Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.),
LivaNova PLC (U.K.),
Symetis SA (Switzerland),
Jenavalve Technology, Inc. (Germany),
CryoLife, Inc. (U.S.),
TTK HealthCare (India),
Colibri Heart Valve, LLC (U.S.),
Lepu Medical Technology Co., Ltd. (China),
Braile Biomédica (Brazil)

Segmentation

The global cardiac valve market is segmented on the basis of types, by diseases, by treatment, and by end users.

On the basis of types, the market is segmented into trans-catheter heart valve, tissue heart valve, mechanical heart valve, and others.

On the basis of disease, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis, and others.

On the basis of treatments, it is segmented into valve replacement, valve repair, and others.

On the basis of end users the market is segmented into cardiac research institute, hospital & clinics, and others.

Regional analysis

The Americas mainly include North America and South America of which North America dominates the market owing to the presence of huge number of patient with cardiac diseases, increasing geriatric population, and increasing healthcare expenditure.

Europe is the second highest revenue generating region in the cardiac valve market. Europe is mainly consist of Eastern Europe and Western Europe. More developed countries of Western Europe such as Germany, France, and the UK are holding the major market share, whereas the East European countries are also growing at a significant rate. Moreover, owing to developing healthcare infrastructure and increasing healthcare expenditure will boost the market growth in this region.

In Asia Pacific, increasing government support for research & development in healthcare domain, growing number of cardiovascular diseases drive the growth of the market in this region.

The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cardiac-valve-market-560

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Endovascular Aneurysm Repair Devices Market Trends, Analysis and Review during 2018 To 2023

Market Scenario

Global endovascular aneurysm repair devices market is likely to grow significantly over the forecast period. It is estimated that the global endovascular aneurysm repair devices market is expected to record a CAGR ~ 6.4 % during the forecast period of 2018 to 2023. The weakening and bulging of the aorta is called aortic aneurysm. The bulging can cause a leak that spills blood into the body. It can direct the blood flow away from the organs and tissues, causing severe complications, such as kidney damage, heart attacks, stroke, and even death. Thus, endovascular repair can be done by placing a stent-graft in an aneurysm through a small hole in the blood vessels in the groin area.

Numerous factors such as reduced recovery times, low-cost hospitalization charges, and technological advancements in repair devices are expected to drive the growth of the market. For instance, in March 2017, Terumo Corporation completed the acquisition of Bolton Medical, Inc. with the acquired company being a leading innovator in thoracic and abdominal stent graft systems, Terumo Corporation aimed to strengthen its growth in vascular graft segment.

However, stringent government regulation, the preferable alternative of open surgery and various complications such as endoleaks and infections may hamper the market growth during the assessment period.

Key players

Cardiatis SA,
Cardinal Health,
Cook Medical LLC,
Endologix, INC.,
Jotec GmbH,
Medtronic plc,
Terumo Corporation,
L. Gore & Associates, Inc.,
BiFlow Medical Ltd,
Boston Scientific Corporation,
Braile Biomédica,
Endoluminal Sciences Pty Ltd,
Endospan Ltd.,
Getinge AB,
Lemaitre Vascular Inc.

Segmentation

The global endovascular aneurysm repair devices market has been segmented into indication, site, anatomy, and products.

The market, on the basis of indication, has been segmented into the abdominal aortic aneurysm, thoracic aortic aneurysm and others.

The market, based on thoracic aortic aneurysm, has been further segmented into ascending aortic aneurysm, descending aortic aneurysm, thoracoabdominal aortic aneurysm, and thoracic arch aortic aneurysm.

The market, on the basis of the site, has been segmented into infrarenal and pararenal.

The market, based on pararenal site, has been sub-segmented into juxtarenal and suprarenal.

The market, on the basis of anatomy, has been segmented into traditional and complex.

The market, on the basis of products, has been segmented into percutaneous EVAR, fenestrated EVAR, aortic stents and TAA grafts, and others.

Regional Market Summary

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The endovascular aneurysm repair devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The Americas is expected to dominate the global endovascular aneurysm repair devices market owing to increasing geriatric population, and well-developed healthcare sector. With the increase in the geriatric population, the prevalence of aneurysms is also expected to rise. The Centers for Disease Control and Prevention (CDC) ranks abdominal aortic aneurysm as one of the top 15 causes of mortality in the United States, but only for those between 85 and 89 years. According to the Centers for Disease Control and Prevention, aortic aneurysms were the primary cause of 9,863 deaths in 2014 in the US.

Europe is expected to hold the second largest position in the global endovascular aneurysm repair devices market. The market growth in this region is attributed to the growing prevalence of aneurysms, availability of funds for research, and favorable reimbursement scenario.

On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to the growing government initiatives for the healthcare sector.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies.

Browse Complete 100 Pages Premium Research Report Enabled with 110 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/endovascular-aneurysm-repair-devices-market-6485

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Veterinary Imaging Market in depth study and analysis published, 2018

Market Scenario

Pet healthcare is trending globally with the focus shifting towards improving veterinary capabilities on all fronts. Veterinary imaging remains one of the key focus areas as animal care providers, veterinaries and animal research institutes increase their efforts towards developing superior veterinary imaging technologies. The global veterinary imaging market was valued at USD 1247.61 Mn in 2017 and is expected to surpass a valuation of USD 1800 Mn by the end of 2023. The arrival of high-quality, dedicated imaging solutions that are meeting various animal care needs characterizes the growing interest of healthcare technology companies in the particular space. A number of reputable animal healthcare bands have stepped up their efforts in developing veterinary imaging systems that are not only efficient but also cost-effective.

Over the years, demand for medical diagnostics and imaging for animals has increased significantly. This can be attributed to the increased level of awareness about importance of good health of animal companions among owners. Greater emphases on keeping both farm animals and companion animals in better health condition is reflecting favourably on the global veterinary.

According to the Maine Center for Disease Control & Prevention, close to three-fourths of emerging infectious diseases that affect humans originate in animals. With rising incidences of zoonotic diseases over the past decade or so, has raised the requirement for the development of appropriate diagnostic measures. Moreover, with pet adoption rising, animals are increasingly becoming a member of the family, and as such, pet owners and animal enthusiasts who work in animal rescue have compelled demand for advancements in diagnostic technology such as veterinary imaging for the detection of chronic diseases. Pet insurance often offers up to 80% reimbursement, and due to the growing demand for advanced diagnostics, pet owners are spending on insurance for their animal companions. The North American Pet Health Insurance Association (NAPHIA) has recorded a 17.2% increase in pet health insurance from 2014 to 2015.

Without pet insurance, however, procedures that involve veterinary imaging modalities are expensive and as such are expected to hamper market growth. The University of Illinois published in a report which found that procedural cost ranged between USD 878 to USD 1,461 depending on the site and inclusion of contrast. However, due to the factors mentioned above and the unrealized potential in the market, regulatory authorities such as the FDA have proposed various guidelines of imaging accuracy which have compelled competitors in the market, both new and existing, to develop innovative products and services which meet these guidelines, thus creating new avenues for growth during the assessment period.

Competitive Tracking

Key players in the global veterinary imaging market that have been analyzed in the report include Fujifilm Holding Corporation, Heska Corporation, Idexx Laboratory Inc, and Canon. Other players include Hallmarq Veterinary Imaging Ltd., Carestream Health, General Electric and others. Market strategies most employed by these competitors include product innovation and investments in R&D pipeline.

Segmentation

MRFR’s report offers a detailed segmental analysis of the market based on product type, by animal type, by therapeutic area, by end users, and by region. By product type, the market is segmented into veterinary imaging instruments, veterinary imaging reagents, and veterinary imaging software. The veterinary imaging instruments segment currently holds the maximum share of the global veterinary imaging market. Conventional imaging systems such as X-ray, CT, ultrasound (US), and MRI are mainly used to evaluate the anatomy but are unable to diagnose any change at the molecular level.

However, with the increased focus towards innovations in the field of veterinary medicine, several new biological imaging reagents have surfaced of late. On the basis of animal type, the market is segmented into small companion animals, large animals, and others. In 2017, the small companion animals segment accounted for the highest market share. Rising trend of pet ownership, greater awareness about pet care and increased expenditure on pet health are some of the factors linked with the segment’s growth.

By therapeutics areas, the market is segmented into orthopedics & traumatology, cardiology, neurology, oncology and others. The orthopedics & traumatology segment is expected to remain highly attractive during the assessment period. Bone injuries are more common among animals, which characterises the prominence of the orthopedics & traumatology segment. In addition, growing demand for accurate diagnostic solutions and availability of cutting-edge animal care facilities is also driving the segment’s growth.

On the basis of the end-user, the market is segmented into hospitals & clinics, academic institutes, and others. The hospitals & clinics segment held the largest segment of the market in 2017 and is likely to retain its top position over 2023. At the same time, use of veterinary imaging in academic institutes is also growing at a rapid pace. The academic institutes segment is slated to witness a relatively higher CAGR during the assessment period.

Regional Analysis

Led by North America, The Americas have the largest share of the global market. The region is witnessing a rising demand for pet insurance as pet owners are becoming more invested in their pets’ health. The rapid adoption of innovative technology offerings in the region is responsible for its leading position in the veterinary imaging market. Europe, with its inclusion of developed countries such as Germany, France, and the U.K. accounts for the second largest market share due to the presence of prominent market players and supportive government initiatives toward pet insurance and pet healthcare.

The Asia-Pacific is set to grow at the most rapid pace with countries such as Japan, China, and India taking the lead. The growing prevalence of nuclear families with a tendency toward pet adoption and increasing investments in pet care have prompted international players to establish their presence in these countries in an effort to tap the potential this region carries.

Browse Complete 138 Pages Premium Research Report Enabled with 171 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com